Reap Double-Digit Dividends in Real Estate the Easy Way: American Capital Agency Corp. (AGNC), Chimera Investment Corporation (CIM)

Page 1 of 2

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some real-estate stocks to your portfolio, the iShares FTSE NAREIT Mortgage Plus Capped Index Fund ETF could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.

The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The iShares ETF’s expense ratio — its annual fee — is a relatively low 0.48%. It also sports a whopping dividend yield above 11%.

American Capital Agency Corp. (NASDAQ:AGNC)This ETF has performed well, beating the world market over the past three and five years. As with most investments, of course, we can’t expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

Why real estate?
Perhaps because there’s a finite amount of it, real estate tends to increase in value over time, though not always in a straight line. Real estate investment trusts (REITs), meanwhile, offer an extra benefit, via their requirement to pay out at least 90% of their income in the form of dividends. Mortgage REITs, such as those below, have some tailwinds, such as falling prepayments, but also some red flags.

More than a handful of real-estate companies had strong performances over the past year. Northstar Realty Finance Corp. (NYSE:NRF) surged 92%, for example, and yields 8%. It has increased its payout by about 80% over the past six quarters. Its revenue has been growing at a double-digit clip over the past few years, and offers the benefit of being diversified between real-estate debt, mortgage-backed securities, and the old-fashioned leasing of owned properties.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!